Peptostreptococcal pericarditis complicating anti-tumour necrosis factor α treatment in rheumatoid arthritis [1]

Annals of the Rheumatic Diseases

Volumn 61, Issue 7, 2002, Pages 653-654

  Harney, S ^a   O'Shea, F D ^a   FitzGerald, O ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CIPEMASTAT; CYCLOSPORIN; INFLIXIMAB; METHOTREXATE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; BACTERIAL INFECTION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; HUMAN; IMMUNOTHERAPY; INFECTION SENSITIVITY; LETTER; MALE; PEPTOSTREPTOCOCCUS; PERICARDITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; PEPTOSTREPTOCOCCUS; PERICARDITIS;

EID: 0036288769     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.61.7.653     Document Type: Letter

References (3)

1. Monoclonal anti TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease
2. Safety of infliximab in clinical trials
3. Evaluation of culture results of specimens from patients with suspected anaerobic infection